Received: from SA1PR19MB7064.namprd19.prod.outlook.com (::1) by
 MN0PR19MB6312.namprd19.prod.outlook.com with HTTPS; Fri, 18 Aug 2023 11:38:27
 +0000
Received: from BN9PR03CA0470.namprd03.prod.outlook.com (2603:10b6:408:139::25)
 by SA1PR19MB7064.namprd19.prod.outlook.com (2603:10b6:806:2b6::14) with
 Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.6678.31; Fri, 18 Aug
 2023 11:38:26 +0000
Received: from BN1NAM02FT021.eop-nam02.prod.protection.outlook.com
 (2603:10b6:408:139:cafe::19) by BN9PR03CA0470.outlook.office365.com
 (2603:10b6:408:139::25) with Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.6699.17 via Frontend
 Transport; Fri, 18 Aug 2023 11:38:26 +0000
Authentication-Results: spf=softfail (sender IP is 80.96.157.89)
 smtp.mailfrom=winner-win.art; dkim=none (message not signed)
 header.d=none;dmarc=fail action=none header.from=newsletter.otto.de;
Received-SPF: SoftFail (protection.outlook.com: domain of transitioning
 winner-win.art discourages use of 80.96.157.89 as permitted sender)
Received: from qkttgbhsjmwfnksijbkrjxkzhstbswa.whbzt3 (80.96.157.89) by
 BN1NAM02FT021.mail.protection.outlook.com (10.13.2.73) with Microsoft SMTP
 Server id 15.20.6699.20 via Frontend Transport; Fri, 18 Aug 2023 11:38:25
 +0000
X-IncomingTopHeaderMarker:
 OriginalChecksum:0B92BF14A3C4FEA28F67C1832455355BBB39CD9E96C4E9D340C75398B6015FD4;UpperCasedChecksum:93CF6F56CDC6162E3978CC1CC31526154BF514969C95126D81ED626939F20172;SizeAsReceived:486;Count:11
Message-Id: <yvBnTkH.26520.816+=phishing@pot@winner-win.art>
From: KetoXplode Gummies Diet V_3üß¥‚Ääüçá‚Ääüçì <otto-newsletter@newsletter.otto.de>
Subject: Personalisierte Prognose f√ºr schnellen Gewichtsverlust ‚úÖ‚è≥
Reply-To: reply_to@winner-win.art
To: phishing@pot
Cc: phishing@pot
Content-Transfer-Encoding: 7bit
Content-Type: text/html; charset=UTF-8
Date: Fri, 18 Aug 2023 13:37:29 +0200
Sender: hello<otto-newsletter@newsletter.otto.de>
X-IncomingHeaderCount: 11
Return-Path: return@winner-win.art
X-MS-Exchange-Organization-ExpirationStartTime: 18 Aug 2023 11:38:26.0329
 (UTC)
X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit
X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000
X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit
X-MS-Exchange-Organization-Network-Message-Id:
 b5737717-c3dd-488a-ea84-08db9fdfa2c3
X-EOPAttributedMessage: 0
X-EOPTenantAttributedMessage: 84df9e7f-e9f6-40af-b435-aaaaaaaaaaaa:0
X-MS-Exchange-Organization-MessageDirectionality: Incoming
X-MS-PublicTrafficType: Email
X-MS-TrafficTypeDiagnostic:
 BN1NAM02FT021:EE_|SA1PR19MB7064:EE_|MN0PR19MB6312:EE_
X-MS-Exchange-Organization-AuthSource:
 BN1NAM02FT021.eop-nam02.prod.protection.outlook.com
X-MS-Exchange-Organization-AuthAs: Anonymous
X-MS-UserLastLogonTime: 8/18/2023 11:31:40 AM
X-MS-Office365-Filtering-Correlation-Id: b5737717-c3dd-488a-ea84-08db9fdfa2c3
X-MS-Exchange-EOPDirect: true
X-Sender-IP: 80.96.157.89
X-SID-PRA: OTTO-NEWSLETTER@NEWSLETTER.OTTO.DE
X-SID-Result: NONE
X-MS-Exchange-Organization-PCL: 2
X-MS-Exchange-Organization-SCL: 7
X-Microsoft-Antispam: BCL:9;
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 18 Aug 2023 11:38:25.9547
 (UTC)
X-MS-Exchange-CrossTenant-Network-Message-Id: b5737717-c3dd-488a-ea84-08db9fdfa2c3
X-MS-Exchange-CrossTenant-Id: 84df9e7f-e9f6-40af-b435-aaaaaaaaaaaa
X-MS-Exchange-CrossTenant-AuthSource:
 BN1NAM02FT021.eop-nam02.prod.protection.outlook.com
X-MS-Exchange-CrossTenant-AuthAs: Anonymous
X-MS-Exchange-CrossTenant-FromEntityHeader: Internet
X-MS-Exchange-CrossTenant-RMS-PersistedConsumerOrg:
 00000000-0000-0000-0000-000000000000
X-MS-Exchange-Transport-CrossTenantHeadersStamped: SA1PR19MB7064
X-MS-Exchange-Transport-EndToEndLatency: 00:00:01.7233204
X-MS-Exchange-Processed-By-BccFoldering: 15.20.6678.031
X-Microsoft-Antispam-Mailbox-Delivery:
	abwl:0;wl:1;pcwl:1;kl:0;dwl:0;dkl:0;rwl:0;ucf:0;jmr:0;ex:0;psp:0;auth:0;dest:I;OFR:TrustedSenderList;ENG:(5062000305)(920221119095)(90000117)(920221120095)(90012020)(91020020)(91040095)(9050020)(9075021)(9100341)(944500132)(2008001134)(4810010)(4910033)(8820095)(9610025)(9525003)(10145022)(9439006)(9310011)(9220031)(120001);
X-Message-Info:
	qZelhIiYnPlgo3oeAkqKQrb/Je8fpvpPmRGjYwLej8PYXc5p/l16IJFNZxCAVLotsuXAdVK6rjyxkFwUB0R2UFdf9mRqnWu30klBUm/YNZuhWwF7/QkomquC1mFZMq6Qv3+Jz4jyl172WJCEsHBSiM4Wi+R8uszF8G1alpYaeuii/jCJ+NKt7qcvRgiXfl3IiHTu4u7Irwq9IHI8T2YObA==
X-Message-Delivery: Vj0xLjE7dXM9MDtsPTA7YT0wO0Q9MTtHRD0yO1NDTD0tMQ==
X-Microsoft-Antispam-Message-Info:
	=?utf-8?B?N3JmWlFIQUhwYnBFcDFHNjJ2NnZleVlGalM0azNiS1krMmhNb2MyS2h1cU5B?=
 =?utf-8?B?NDRFK0xpdC9YSXFEREpNT0RiUzZKZUg2N1EyRGdhdEdZL0trOWxHYitTQjNl?=
 =?utf-8?B?bkUzRmVTdkR2TXJEVUorNWVKbTRyTThBYmJKK3RML2tVNEFQNW80TnhpbC9K?=
 =?utf-8?B?c256VGJjZ1ZjNmw1SWdkbkhVWUVlVHh0T0UrL2VvVTRWdng3dzRYVy9BZFpC?=
 =?utf-8?B?cXhuWXJ2SVNqSithbi9QQVhQM2IyS05zeXpJcEhDbTkxb0FBci95MS94QWtY?=
 =?utf-8?B?NnJBL3FFVm84SktSWnBFYWRIeEVDanZjZWgyUUQ4UDRWMnlGMnFOSmlBWUNk?=
 =?utf-8?B?WW9PenVrcXZxNDJ4OUlncFRkZXNjMkg0Q3lYRXdVVndkaHV1SThYdFZBY3JM?=
 =?utf-8?B?anZHaUZwNFVTc3NCL0p5dTJPZXZPUCtnZS85T0plMHZ2WWFLbm5kaFB1RlFV?=
 =?utf-8?B?cnJYTk9WQjNTWHp6NkxDM1RBbmxaS1NzVi9RRDRVT05LSmdZa1R6OHRxZ1Bk?=
 =?utf-8?B?cGYwaEFCWWZnaXJXeGl2Qnh6R250UVB0UVptN29rWVhuZjFQS0ZmaHUwMmYr?=
 =?utf-8?B?SEZYemQrR0RteE80cWZRcE1Gb3Z1M203L2pWaXNtVnM3U2ZtVDU1QnYyNUdy?=
 =?utf-8?B?NS9XSCtBdHFoMGN4Z3BjZGFCdi9VNmhyWlFTZFZrQUp3OTRpWnkwYWJPWkpu?=
 =?utf-8?B?alhoQkxjc2J2aUtPdkhJcktRV0NHUW9Za3NPYzl2cWY0a01kcDQ2Um5iRE9z?=
 =?utf-8?B?MC8yRHFreklvVnZRZWQ1N2QzZTI3TkM0OW9NZ0lua3MrYk5ZODgySUNvT3cy?=
 =?utf-8?B?cTdvQ0tVNGNEVytjaVJrSTZmSEZYb2x5N3RGQkF0cDBGWEFKUGFCam1VV3F3?=
 =?utf-8?B?QmRrdkE0ZmtxNDRPd09XK0ZyTXd6SVNJT1c0UkpzSHBrbmx5TmZmaWg1a2dy?=
 =?utf-8?B?em05Q2pwS291TmU1WlVlWWViQmlOaEN6SXYzNFoxMktzQ0cwQkhEN3p2dTRj?=
 =?utf-8?B?b2haZkt0Uk9wSFJNZHRRcUMrdC9LeTV5SEFtenZ2VzZUREpacEtnOGdPbzNu?=
 =?utf-8?B?bWJLbUw3dTBtN1lONGhoVmxsbDR3SXo4V3l2eTBHQjFqbmRqZ1JPaFJLbDRB?=
 =?utf-8?B?THQ4T2x4ZnowUGM3bFc4YkszNDdIQkdBRmp4UlBTM3cvZlVmTXhjK0ZjWS9M?=
 =?utf-8?B?aUZFdHRhY0ozZEFVbG9iUXN0RzBPNUxsNjdmeGJoclQvWE9rWU5WbHRSVDE3?=
 =?utf-8?B?U3VYYUJETFUyblFvNFFUMlk2SkFQTmpva2lNVnA0YXErQnQ1VUVTQmc1NXpQ?=
 =?utf-8?B?YXRiay9qRWg5UTFrQ3B5RVZrYVFTRHM3MnZiNDQ4SHZxMTVDL2ZEOFRyMWxP?=
 =?utf-8?B?NVFJVkJ0ajFHNWRlNERjbDZtbGtiVkF4bmVteTUzMFM4RTU1ZGptMFM1WkZo?=
 =?utf-8?B?SjZDQVhjQnlUeW1mSGlBYytESFZBMmdtUC9lWTBTZGhNSTArcThqMWJ4Mlpo?=
 =?utf-8?B?Q21IUmVrYm9PZmxoMWdtbkkyeUREaHRNMStFUEkvT3gvKzdwbVJkVGlCNTJa?=
 =?utf-8?B?dUtMNGFjdzBXaW1Da0pwY0Jld21qeUV4RmFlWlJWUGpEYXdhMVh3WXd3R3Zj?=
 =?utf-8?B?Z1A3bSszaUJpZHhGUXlFY3VLeTNYT244N2JFZVQ2SVR1YnpEV2p5b3diN1I3?=
 =?utf-8?B?L000aXV4MmIxK21UUW5YV293WnFsaHRqVjZGaU80V1JaVkUvcTVZSUdBNXpQ?=
 =?utf-8?B?S2JSK05NYldWZU1ac0ljZDFYekVpTkhRaXJxMklBRngrWlI0dmk4enlqRFFG?=
 =?utf-8?B?MzJxTXZLZlh5OFA0eXYzZWhsK1crWXZPTTgrV3hFcmk4TG9UMmcvNUgxbUVY?=
 =?utf-8?B?dlNUUVpNUzFvYzZZc1BnREpzOFVxcUIzNXNJMGlRQVI2ZUk4L2ZRTnh5dU5I?=
 =?utf-8?B?aCtUV1dyQ3A3dHpmWVEvRmJRTXdLRjl2Kzc2cmhrMllGaW5rbGJMVURnTVAw?=
 =?utf-8?B?Yk95eXNmYWJNUjB6cUVJZWRJb05TNzYxUldkajdWQzU5NXd2NHRDTE5PNDdI?=
 =?utf-8?B?U2tvM2hXSEQrQlVYUjRSMkV6YU4wUTJvSXdxRHlPMVkzaEZZWG9MOFpKWkp5?=
 =?utf-8?B?Yjk0S0krcW5ZTXRxZmJ4VE83MlAwTW9Yb0IrV1dQaCt0THVDNnl0ait0Zzd3?=
 =?utf-8?B?UVV1em1kczltVHJxc05WVG9jdWgva1UybHYyZVA1Y0FRM1dJWHgySWtoYnlF?=
 =?utf-8?B?a1NwNVY3WHZYcGJIa2k1Nk5IdEZGYUoyaHFabkJ5QWJzbTg5a0d5cWIyaTRC?=
 =?utf-8?B?S3llQUUwZGw5Q0xKQTc1czBmNkxHSjc4VFpvbFlTYkMzSm9hSmVqVWVOVEJn?=
 =?utf-8?B?M2J0dE8yUHBLdjFkMklwSVZPVExTczlheDdkWFhTKzFCbC84Wlg5Z1U2K0lX?=
 =?utf-8?B?S0FWaFdGQVpsRENKTWtDakZ5Tzgwb2RwbWM1M3NrN0h6cjFEcWJ5dUtrR2tL?=
 =?utf-8?B?aWNOZTlqRnFNOUVOaXFqZTFvZ003M1VFTC80MVVXQUtxaDhxd3J5dXNZc0po?=
 =?utf-8?B?dWtHZEpKeHBNS2NGRExEamZPNUl6bFU3eXRNV1F2bGFaZ0ExWElxZldqSmQy?=
 =?utf-8?B?UHhvSUI2NFBBMEJNL05PaGRuOGxLTWc4NUt3M3hXaDFjOFVCREJHY0dIakls?=
 =?utf-8?B?L2E5ZUVFS29pek9DYjI0aVBlNGFaZldJZ3hHeTZTYUFEUy9sMzNzTEpic2pp?=
 =?utf-8?B?UFNvUG13a2w5SmNlVjNCTjdwMDgrUWVvalFIV1duaEdtVE1lVXVIK0w0TVBa?=
 =?utf-8?B?dVFGVjZrcjAyckR5Mmd0azlYNHFGdTI2NjJSVVMrbzB2d0NoK0JwOEhOTjUw?=
 =?utf-8?B?cGNmMkZrTXFPQmRISTgzc0k1cjhoR2g4ZlJacE1JYUVBc3lCSVhpMU1xSTN0?=
 =?utf-8?B?TW1EU29ZYkNiRmNvZGZ2eHY4YXRMTzIrWDZoR2VxSlg2N0JsRFlKUld3NzBW?=
 =?utf-8?B?aGtKOTZMc3FLR1VOYVlabjQ3N2dGWTYybkZaRXFVbmgvNGRDUG1CTFFwcGJZ?=
 =?utf-8?B?NFltWFMxbUhqRTdXM1ZUV0dQQndYSGVlbDVsRVNKNVdpaWxKSGRNV05FMzh6?=
 =?utf-8?B?Sk9QWUFtbUZZSGRBOTgwb25pVXRYWWl0MWc3cUlQK1hEdzRheWNXNGNEbVpv?=
 =?utf-8?B?R1lTRWpSSzBta1dDVGsrWnNGMmVieDFtSGRkdHlBZlB3NkMxUUNySXNyMkxO?=
 =?utf-8?B?d1NLSVZrZi8rRzVmMWhKQmVpL1JKakU5K0p5ekNaRWlkZEljY0xEd0tVS2k4?=
 =?utf-8?B?V2V2L0pTUFVocE8yTGVWVWtpUGF0NHdUWVJPRWlBZWUwZHhvSXR6SDkzMkZ4?=
 =?utf-8?B?OGVIekorYmZab250Z0ZFa05YUUxSd1pYVm9EcUtXdGJ1WG5VME5ZQ2JCVWIx?=
 =?utf-8?B?VG9MZU0vdW1Wd1ZaRmI4ZXo3d0RNRWF2Wi96cUgzVGFkOFBISmJhVWZ0b0li?=
 =?utf-8?B?Zm95eHBpZUxlSHdsOGgxRmFFQlZ1Z2plRVU3cWtPMjM2YkthdnBWNmtrUGxU?=
 =?utf-8?B?eXh0UGgwSFlXUHFraEx1cHJXeHBSYUw3TUNpUng1Y3BjbS9IbGlUUllCMlE4?=
 =?utf-8?B?TnZSaXdRekZ1M2VaUWR6Q2dqSlM4czBxMG5xNXhVQndXYVlzMEpNcSt6MTA5?=
 =?utf-8?B?MTl0SDl6aUNxcEZSTjczOVZ5Y1Q5QWh5SnIrdVJhQW84aXhEQXVCVVAzdzRD?=
 =?utf-8?B?dTg5SHcyL2tySzBnZmpRREhIdFZpTkllY1JVbWNzSFg3YmRTc2paMTN0aCtz?=
 =?utf-8?B?c2ZQdmFGZDhDUExMMUJYQ2JpejFUeUFUa2I0NkxNUnlhSzRWVzlFMThEZnBI?=
 =?utf-8?B?RlFUMldCSnF4TlBZdXhiYlZZL25POTNuekJ4VlFTdVBGWVIzZlJwbDZlKytG?=
 =?utf-8?B?Q2U4ZzhuWDUxby9TK01uei9iT2NkdVZGWjZialB4dUp1WVlNODVJd2U5T3Ja?=
 =?utf-8?B?Mnh5WjhDdDBPMkVUYmpFZUJ3KzRkcGxLYVVRT3Q5Nyt1b2tXckdMbWNlSlNQ?=
 =?utf-8?B?V1lnMGp0aHFjajNBRGFzUVZlb09lazlWTmp6VzJyQnBQRUVKWHVkRWtQRGJo?=
 =?utf-8?B?NXRhanBwc3c4NXRZaWh2UTUwR0tCK3U1UEZ0azdFTWorSU9XUHlmeE92bTk2?=
 =?utf-8?B?N2VaKzhDV1ZmVGpFZXJOakMrbHBuQWhpd0tQNFk3bkRqOE1LSldsNTk5SThn?=
 =?utf-8?B?WkNDYlhBN2Y0QlFSY0ZHQ2V3MnU0RGtnd1BrbnFVZnJxZVhBckpmSlZaM3h1?=
 =?utf-8?B?cXFycjBTWjNxSDVsNytPWXNRUS9yRVJtWjF4d0tKbDJjQ1BuNDlNRzJleHZx?=
 =?utf-8?B?K0pQak5qZm9ITStjYWxiNHZIZlBFVmd1UVVnPT0=?=
MIME-Version: 1.0

<!doctype html><html><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><title>KetoXplode</title>  </head> <body centermargin="0" topmargin="0" marginwidth="0" marginheight="0" bgcolor="#eeeeee"> <center> <a href="https://t.co/mvSRObYnj7" target="_blank" style="color:#202020;text-decoration:none">age ist der Vorrat an KetoXplode Apple Gummies aufgebraucht. Juni begrenzt.<table align="center" border="0" cellpadding="0" cellspacing="0"> <tr> <td> <!--Preheader--> <table align="center" width="100%" style="max-width:700px;"> <tr> <td align="center" style="color:#202020; font-family:Helvetica, Arial, sans-serif; font-size:10px; max-width:700px; font-weight:100; padding-top:5px; padding-bottom:5px; line-height:17px"> Aufgrund der extrem hohen Nachfr Beeilen Sie sich! </td> </tr> </table> <!--Preheader-->  <table align="center" width="100%" border="0" cellpadding="0" cellspacing="0" style="max-width:700px;"> <tr> <td> <!--Content--> <table align="center" border="0" cellpadding="0" cellspacing="0" width="100%" style="max-width:700px; background-color:#f8f3f0;">  <tr> <td align="center" style="background-color:#fffbf9;">

<img border="0" src="https://naintl.s3.eu-west-1.amazonaws.com/_CTJU/2020/2023/June/13/25345_DEATCH_KetoXplode_GummiesDiet.png" style="width:100%" alt="DERMA 360 ANTI-AGING" style="color: #fffbf9; font-weight: bold; font-size: 30px; text-align:center; margin:0; padding:0; border:none; display:block; max-width:100%; font-family:Helvetica, Arial, sans-serif;">
<img border="0" src="//naintl.s3.eu-west-1.amazonaws.com/_CTJU/2020/2023/June/13/25345_DEATCH_KetoXplode_GummiesDiet.png" style="width:100%" alt="DERMA 360 ANTI-AGING" style="color: #fffbf9; font-weight: bold; font-size: 30px; text-align:center; margin:0; padding:0; border:none; display:block; max-width:100%; font-family:Helvetica, Arial, sans-serif;"></a> </td> </tr> <tr> <td> <table align="center" width="70%" style="max-width:700px; background-color:#f8f3f0;padding-bottom: 20px;padding-top: 20px;"> <tr> <td align="center" style="background-color:#f8f3f0; padding-top:15px; font-family:Helvetica, Arial, sans-serif; font-size:32px; line-height:42px; color:#2a2a2a; font-weight:300; text-align:center;">

<h2 style="color:#c84686"><b>SCHMELZEN<br>FAT SCHNELL!</b><br><h2>

<h5 style="background-color:#a44987;color:#fff">OHNE DIAT ODER SPORT</h5><br>

<h2 style="color:#c84686"><b>üòçKetoXplodeüòç</b><br><br>üß¥‚Ääüçá‚Ääüçì‚Ää<h2>
</td></tr>

<tr> <td align="center" style="background-color:#f8f3f0; padding-top:15px; font-family:Helvetica, Arial, sans-serif; font-size:32px; line-height:42px; color:#2a2a2a; font-weight:300; text-align:center;"> Individuelle Prognose f√ºr Ihr schnelles Gewichtsmanagement </tr> </table> </td> </tr> <tr> <td align="center" style="background-color:#f8f3f0;"> <table width="50%" cellpadding="0" cellspacing="0" border="0"> <tr> <td align="center"> <a href="https://t.co/mvSRObYnj7" target="_blank" style="color:#f8f3f0; text-decoration:none;"> <table width="100%" height="45" cellpadding="5" cellspacing="5" border="0" style=" background-color:#a44987; border-radius:04px;"> <tr> <td align="center" style="color:#f8f3f0; text-decoration:none; font-size:16px; font-family:Helvetica, Arial, sans-serif; font-weight: bold;text-transform: uppercase;"> ERHALTEN SIE IHRE BESTELLUNG! </td> </tr> </table> </a> </td> </tr> </table> </td> </tr> <!--Button--> </table> <table align="center" border="0" cellpadding="0" cellspacing="0" width="100%" style="max-width:700px; background-color:#f8f3f0;"> <tr> <td> <table align="center" width="80%" style="max-width:700px; background-color:#f8f3f0; padding-top:15px;padding-bottom:10px;"> <tr> <td align="center" style="background-color:#f8f3f0; padding-top:10px;padding-bottom:15px;font-family:Helvetica, Arial, sans-serif; font-size:16px; line-height:28px; color:#2a2a2a; text-align:left;">  Der Nutzen und Erfolg der einzigartigen KETOXPLODE-Formel ist durch Studien belegt. Anhand dieser Informationen k√∂nnen wir berechnen, wie viel Zeit Sie ben√∂tigen, um Ihr Wunschgewicht zu erreichen. </td> </tr> <tr> <td align="center" style="background-color:#f8f3f0; padding-top:10px;padding-bottom:15px;font-family:Helvetica, Arial, sans-serif; font-size:14px; line-https://t.co/eYVtqVunRCheight:28px; color:#2a2a2a; text-align:left;">  Finden Sie heraus, wie viel Gewicht Sie mit einer KETOXPLODE-Anwendung verlieren k√∂nnen und wie schnell. KETOXPLODE ist derzeit rezeptfrei erh√§ltlich.<br> <a href="https://t.co/mvSRObYnj7" style="text-decoration: underline; color:#0a4abb;font-weight: bold;"> Finden Sie heraus, ob KETOXPLODE f√ºr Sie pers√∂nlich das Richtige ist und wie viel Zeit Sie ben√∂tigen, um Ihre pers√∂nlichen Ziele zu erreichen.</a> </td> </tr>  <tr> <td>&nbsp; </td> </tr> </table> </td> </tr>  </table> </td> </tr> </table></a></center> <center><table align="center" width="100%" style="max-width:700px;"> <tr> <td align="center" width="100%" style="font-family:Helvetica, Arial, sans-serif; font-size:10px; color:#202020; line-height:15px; padding-top:10px;"> Gehen Sie <a href="http://bsq2.firiri.shop/TjdGSUxUbWc1QkgrdlBBbnhWaXNZdE1CVEdSWTAzbFZmZTRRSlZHUHFxdTdFSEdOOXpzMGtpcWVCbzUxQU5lV2RpVmgxQXkzT2ZwdnMvTE1Ta0JTVlE9PQ__" style="color:#202020;">hier</a> oder schreiben Sie an: <br> 616 Corporate Way Ste.2-9092 <br> Valley Cottage, NY 10989 </td> </tr> </table> </td> </tr> </table>  </center></body></html>

<center><br><br><span style="color:#888;font-size:9px;font-family:verdana;display:block;text-align:center;margin-top:10px">click <a href="http://bsq2.firiri.shop/TXJCdGxDTnFXbmxTc3BFSHlQaVIxb0pvYmVzRGlLY09GMCswL2V3TWZsbU4zVUwrN3NvdUdWSDJiZ25oQ1BFWkU2U3c2WEUrT2ZJV2paVTlUOUVNblE9PQ__">here</a> to remove yourself from our emails list</span><br><br><img alt="" src="http://bsq2.firiri.shop/M2RJUHVrcUR6dW9VNWJKWGpHZjh0WTlFRkVnNVNKcnVMUzVjWTlRUmZUV2Fhc1pmazFYcWRBeDBzc1ZJZGVqejRLMHNPYWhqeFZxL1ZKZVdUb0t2NkE9PQ__" width="1px" height="1px" style="visibility:hidden"></center>
